Thyrocare Technologies Ltd approves Q2 FY27 results, with consolidated revenue of ₹270.81 crore and net profit of ₹15.22 crore
- Revenue rose 25.1% year on year and 12.8% sequentially; EBITDA margin was 33.0%, excluding other income.
- Net profit fell 68.2% year on year and included a ₹44.98 crore exceptional impairment charge.
- Limited-review conclusion was unmodified; certain subsidiaries’ and an associate’s results were not reviewed and were stated to be immaterial to the Group.